Page 10 - Demo

Merck, 2024%u2019%u00fcn %u00fc%u00e7%u00fcnc%u00fc %u00e7eyre%u011finde g%u00fc%u00e7l%u00fc b%u00fcy%u00fcme hedefini s%u00fcrd%u00fcr%u00fcyorMerck accelerates growth, driven by all business sectorsMerck, 2024 y%u0131l%u0131n%u0131n %u00fc%u00e7%u00fcnc%u00fc %u00e7eyre%u011finde organik sat%u0131%u015flar%u0131n%u0131 %3,8 ve FAV%u00d6K%u2019%u00fcn%u00fc %16,9 art%u0131rarak g%u00fc%u00e7l%u00fc bir b%u00fcy%u00fcme kaydetti.%u00d6nde gelen bilim ve teknoloji %u015firketlerinden Merck, 2024 y%u0131l%u0131n%u0131n %u00fc%u00e7%u00fcnc%u00fc %u00e7eyre%u011finde b%u00fcy%u00fcmesini h%u0131zland%u0131rd%u0131. %u015eirket, faaliyet alan%u0131ndaki %u00fc%u00e7 sekt%u00f6rde de sat%u0131%u015f ve kazan%u00e7larda organik art%u0131%u015flar elde etti. Buna g%u00f6re %u015firket, daha %u00f6nce a%u00e7%u0131kland%u0131%u011f%u0131 gibi 2024 mali y%u0131l%u0131nda k%u00e2rl%u0131 b%u00fcy%u00fcmeye d%u00f6nme yolunda ilerlemeye devam ediyor.Merck Y%u00f6netim Kurulu Ba%u015fkan%u0131 ve CEO%u2019su Bel%u00e9n Garijo, %u201cBekledi%u011fimiz gibi %u00fc%u00e7%u00fcnc%u00fc %u00e7eyrekte b%u00fcy%u00fcme rotam%u0131z%u0131 s%u00fcrd%u00fcrd%u00fck. 2024 mali y%u0131l%u0131nda k%u00e2rl%u0131 b%u00fcy%u00fcme beklentimizi teyit ediyoruz%u201d dedi. %u201cFaaliyet g%u00f6sterdi%u011fimiz pazarlar g%u00fc%u00e7l%u00fc b%u00fcy%u00fcme trendlerini yakalamaya devam ediyor ve %u00e7ok sekt%u00f6rl%u00fc portf%u00f6y%u00fcm%u00fcz bu olumlu geli%u015fmelerden faydalanmak i%u00e7in en iyi %u015fekilde konumlanm%u0131%u015f durumda.%u201dHer %u00fc%u00e7 i%u015f sekt%u00f6r%u00fcndeki olumlu i%u015f performans%u0131 sayesinde Merck, 2024 y%u0131l%u0131n%u0131n %u00fc%u00e7%u00fcnc%u00fc %u00e7eyre%u011finde net sat%u0131%u015flar%u0131n%u0131 5.266 milyon Euro%u2019ya y%u00fckselterek %3,8%u2019lik organik b%u00fcy%u00fcme elde etti. 2,0%u2019l%u0131k olumsuz kur etkileri dikkate al%u0131nd%u0131%u011f%u0131nda, Grup sat%u0131%u015flar%u0131 bir %u00f6nceki %u00e7eyre%u011fe k%u0131yasla toplam %1,8 oran%u0131nda artm%u0131%u015ft%u0131r.FAV%u00d6K organik olarak %16,9 oran%u0131nda art%u0131%u015f g%u00f6stermi%u015ftir. Bu art%u0131%u015fta sat%u0131%u015flardaki b%u00fcy%u00fcme, s%u0131k%u0131 maliyet disiplini ve Sa%u011fl%u0131k Hizmetleri alan%u0131ndaki ara%u015ft%u0131rma ve geli%u015ftirme harcamalar%u0131n%u0131n ge%u00e7ici olarak azalmas%u0131 etkili olmu%u015ftur. 5,0%u2019l%u0131k negatif kur etkisi de dahil olmak %u00fczere, kazan%u00e7lar toplamda %11,9%u2019luk %u00e7ift haneli bir art%u0131%u015fla 1.618 milyon Euro%u2019ya ula%u015fm%u0131%u015ft%u0131r. Bir %u00f6nceki %u00e7eyrekte %27,9 olan FAV%u00d6K marj%u0131 %30,7%u2019ye y%u00fckselmi%u015ftir. Hisse ba%u015f%u0131na kazan%u00e7 2,30 Euro olarak ger%u00e7ekle%u015fmi%u015ftir. Merck achieved robust third-quarter growth in 2024, with organic sales up 3.8% and EBITDA pre rising 16.9%Merck, a leading science and technology company, accelerated its growth in the third quarter of 2024. All three business sectors achieved organic increases in sales and earnings. Accordingly, the company remains on course to return to profitable growth in fiscal 2024, as previously announced.%u201cAs expected, we continued our growth course in the third quarter. We confirm our guidance of profitable growth in fiscal 2024,%u201d said Bel%u00e9n Garijo, Chair of the Executive Board and CEO of Merck. %u201cThe markets in which we operate continue to experience robust growth trends and our multi-industry portfolio is optimally positioned to benefit from these positive developments.%u201dDue to the positive business performance in all three business sectors, Merck grew its net sales to %u20ac 5,266 million in the third quarter of 2024, achieving organic growth of 3.8%. Taking negative foreign exchange effects of 2.0% into account, Group sales grew by a total of 1.8% compared with the year-earlier quarter.EBITDA pre rose organically by 16.9%. This was driven by sales growth, strict cost discipline and the temporarily lower spend on research and development in Healthcare. Including negative foreign exchange effects of 5.0%, earnings saw double-digit growth of 11.9% to %u20ac 1,618 million overall. The EBITDA pre margin increased to 30.7% compared to 27.9% in the yearearlier quarter. Earnings per share pre amounted to %u20ac 2.30.Haber / News8Kaynak / Source: https://www.merckgroup.com/en/news/q3-2024-14-11-2024.html